Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 18, 2012Clinical Cancer ResearchOpen Access

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer—Opportunities, Challenges, and Limitations

View Full Paper
Ask AI
Bookmark
Share

Authors

JEJeyanthy EswaranSt. Jude Children's Research HospitalDLDa‐Qiang LiJiangsu UniversityASAnil A. Shah

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eswaran et al. (2012) studied this question.

synapsesocial.com/papers/6a7082e28031ec7bb1dc65cdhttps://doi.org/10.1158/1078-0432.ccr-11-1952
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein2005 · 47 citations
  2. 2LKB1 Suppresses p21-activated Kinase-1 (PAK1) by Phosphorylation of Thr109 in the p21-binding Domain2010 · 37 citations
  3. 3Differential Effects of PAK1-activating Mutations Reveal Activity-dependent and -independent Effects on Cytoskeletal Regulation1998 · 201 citations
  4. 4Regulation of Microfilament Reorganization and Invasiveness of Breast Cancer Cells by Kinase Dead p21-activated Kinase-12000 · 167 citations
  5. 5Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes2008 · 201 citations